An investigator-initiated clinical trial led by Professor Manabu Muto of the Graduate School of Medicine (involving the seven institutions listed below) has demonstrated that photodynamic therapy (PDT) using Laserphyrin (talaporfin sodium) and semiconductor laser can be effective as a salvage treatment for esophageal cancer patients with local failure after chemoradiotherapy (CRT) or radiotherapy (RT); the procedure achieved a high complete response rate without serious side effects.
Read the source article at Medical Xpress
Advertisements